LINCOLNSHIRE, Ill. & BAUDETTE, Minn.--(BUSINESS WIRE)--
BioSante Pharmaceuticals, Inc. (BPAX) and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that each company will hold a special meeting of its stockholders on Wednesday, June 19, 2013 to consider and vote on certain matters in connection with the proposed merger of a subsidiary of BioSante into ANI pursuant to the amended and restated agreement and plan of merger dated April 12, 2013.
BioSante and ANI have fixed the close of business on May 8, 2013 as the record date for the purpose of determining the stockholders who are entitled to notice of, and to vote at, their respective special meetings of stockholders. The special meeting of BioSante stockholders will be held at 8:00 a.m., Central Time, at BioSantes corporate office located at 111 Barclay Boulevard, Lincolnshire, Illinois 60069. The special meeting of ANIs stockholders will be held at 9:00 a.m., Eastern Time, at the offices of MVP Capital Partners located at 259 N. Radnor-Chester Road, Suite 130, Radnor, Pennsylvania 19087. BioSante and ANI stockholders are encouraged to read the definitive joint proxy statement/prospectus in its entirety as it provides, among other things, a detailed discussion of the proposed merger, the merger agreement and the process that led to the proposed merger.
The issuance of BioSante shares in connection with the merger will require the affirmative vote of a majority of the BioSante shares present and entitled to vote at the BioSante stockholders meeting called to consider such issuance (assuming a quorum is present). Unvoted shares will not prevent the issuance of shares in the merger from being approved. The merger also must be approved by ANI stockholders. In addition to the approval of BioSante and ANI stockholders, the completion of the merger is subject to other customary closing conditions.
BioSante stockholders who need assistance in voting their shares or who have questions regarding BioSantes special meeting may contact AST Phoenix Advisors toll-free at (877) 478-5038.
BioSante also announced today that its board of directors has set the close of business on June 19, 2013, the date of the special meeting of BioSante stockholders, as the record date with respect to the anticipated distribution of contingent value rights (CVRs), to holders of BioSante common stock, providing payment rights arising from a future sale, transfer, license or similar transaction(s) involving BioSantes LibiGel (female testosterone gel), including if ANI were to market LibiGel on its own based on BioSante clinical data with less than $2.5 million further spending in clinical development and related costs. Although BioSantes board of directors has set the record date for such distribution, BioSantes board of directors has not authorized yet or declared the distribution and does not intend to do so until after BioSante stockholders and ANI stockholders have approved the merger and all related matters being submitted to a vote of such stockholders. The CVR distribution will be effected immediately prior to, but contingent upon, completion of the merger.
BioSante and ANI expect to close the merger as soon as practicable following receipt of approval of the proposals by BioSante stockholders and ANI stockholders at their respective special meetings.
Under the terms of the merger agreement, if the proposed merger is completed, a newly formed subsidiary of BioSante will merge with and into ANI, with ANI continuing as the surviving company and a wholly owned subsidiary of BioSante. Upon completion of the merger, BioSante will issue to ANI stockholders shares of BioSante common stock such that the ANI stockholders at the effective time of the merger will own 57 percent of the combined companys shares of common stock outstanding, and the BioSante stockholders at the effective time of the merger will own 43 percent.
Upon completion of the merger, the combined company will operate under the leadership of the ANI management team, with Arthur S. Przybyl serving as president and chief executive officer. In addition to Mr. Przybyl, the board of directors of the combined company is expected to have two current directors from BioSante and four current ANI directors.
About BioSante Pharmaceuticals, Inc.
Continued here:
- The truth about guys and sex: They fake it, too - April 29th, 2013 [April 29th, 2013]
- Rock-It Man male sexual performance drug recalled - April 29th, 2013 [April 29th, 2013]
- Judge approves class-action lawsuit over erectile dysfunction link to prostate, baldness drugs - April 29th, 2013 [April 29th, 2013]
- Apricus, Innovus tackle bedroom disorders - April 29th, 2013 [April 29th, 2013]
- Ask Dr. K: Precautions for male bicyclists - April 29th, 2013 [April 29th, 2013]
- Advanced Male Medical Center Announces Hiring of Erick Salazar - April 29th, 2013 [April 29th, 2013]
- Faking the big O - April 29th, 2013 [April 29th, 2013]
- Priapus Shot - Video - April 29th, 2013 [April 29th, 2013]
- Trimel Submits New Drug Application for CompleoTRT(TM) to FDA - April 30th, 2013 [April 30th, 2013]
- 4 Bio Stocks to Buy Today - May 1st, 2013 [May 1st, 2013]
- Class-Action Lawsuit on Propecia Erectile Dysfunction Approved: Now, AttorneyOne Can Provide Advice - May 3rd, 2013 [May 3rd, 2013]
- Trimel to Report First Quarter 2013 Results and Host Investor Call - May 3rd, 2013 [May 3rd, 2013]
- Acupuncture Presentation Part 2 - Video - May 6th, 2013 [May 6th, 2013]
- Sixty-One Per Cent of Women Say their Sex Lives are Suffering Due to a Condition of Menopause - May 7th, 2013 [May 7th, 2013]
- Apricus Biosciences Announces Poster Presentation of Vitaros(R) Data in Men Previously Unresponsive to PDE-5 ... - May 8th, 2013 [May 8th, 2013]
- Dietary Supplement Lightning Rod Capsules Recall - May 8th, 2013 [May 8th, 2013]
- Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call - May 8th, 2013 [May 8th, 2013]
- Why Wait? Enlast Personal Male Lubricant. Stop Premature Ejaculation In Its Tracks With Enlast.flv - Video - May 9th, 2013 [May 9th, 2013]
- Searching For Male Fountain of Youth? Go Exercise - May 11th, 2013 [May 11th, 2013]
- BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results - May 11th, 2013 [May 11th, 2013]
- Apricus Biosciences Provides First Quarter 2013 Corporate Update - May 11th, 2013 [May 11th, 2013]
- DGAP-News: Apricus Biosciences Provides First Quarter 2013 Corporate Update - May 11th, 2013 [May 11th, 2013]
- Sex and the elderly male - May 12th, 2013 [May 12th, 2013]
- Couple sues state over toddler's sexual-reassignment surgery - May 15th, 2013 [May 15th, 2013]
- Columbia couple sues state over toddler’s sexual-reassignment surgery - May 15th, 2013 [May 15th, 2013]
- If Sexual Dysfunction Were a Virus, "It'd Be Pandemic": Expert - May 16th, 2013 [May 16th, 2013]
- Couple files groundbreaking lawsuit over child’s sexual-reassignment surgery - May 16th, 2013 [May 16th, 2013]
- The Dangers Lurking in Male Sexual Supplements - May 17th, 2013 [May 17th, 2013]
- West Jordan man pleads guilty to falsely advertising, selling Viagra-like drug - May 17th, 2013 [May 17th, 2013]
- Manning up to the church - May 20th, 2013 [May 20th, 2013]
- Boy who manned up to the church - May 20th, 2013 [May 20th, 2013]
- The low-down on erectile problems - May 21st, 2013 [May 21st, 2013]
- Study: Genital Warts May Lead to Sexual Dysfunction; polyDNA Recommends Gene-Eden-VIR Against the Genital Warts Virus - May 22nd, 2013 [May 22nd, 2013]
- Quit smoking for a better sex life - study - May 22nd, 2013 [May 22nd, 2013]
- If It Doesn’t Make Us Nymphos, Female Viagra Will Save Monogamy - May 23rd, 2013 [May 23rd, 2013]
- Erectile dysfunction drugs sold as herbal medicine - May 24th, 2013 [May 24th, 2013]
- Heart failure ups risk of male menopause 4 fold - May 25th, 2013 [May 25th, 2013]
- Heart failure accelerates male 'menopause' - May 25th, 2013 [May 25th, 2013]
- New Asia-Pacific Sexual Satisfaction Study Pulls Back the Covers on Relationship Tension Facing Couples - May 28th, 2013 [May 28th, 2013]
- Heart Disease Accelerates Male Menopause - May 29th, 2013 [May 29th, 2013]
- Igniting woman's sexual desire is more than popping pill - May 30th, 2013 [May 30th, 2013]
- Warning: 'Natural' sex supplements may not be - May 31st, 2013 [May 31st, 2013]
- Dangers of sex supplements - May 31st, 2013 [May 31st, 2013]
- Warning: Men's natural sex supplements may not be - May 31st, 2013 [May 31st, 2013]
- Sex is doctor's life's work - June 1st, 2013 [June 1st, 2013]
- Sex is life's work for doctor - June 3rd, 2013 [June 3rd, 2013]
- Sexual stress common in men - June 6th, 2013 [June 6th, 2013]
- Sexual performance anxiety - June 6th, 2013 [June 6th, 2013]
- Affirm XL, Inc. Re-launches U.S. Made Sexual Enhancement Dietary Supplement - June 6th, 2013 [June 6th, 2013]
- Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction - June 11th, 2013 [June 11th, 2013]
- DGAP-News: Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction - June 11th, 2013 [June 11th, 2013]
- BPA linked to obesity risk in puberty-age girls - June 13th, 2013 [June 13th, 2013]
- Baldness drug curbs interest in alcohol, study says- Fla. mom dies after butt enhancing injections - June 14th, 2013 [June 14th, 2013]
- Anti-baldness drug can cause men to lose interest in alcohol - June 14th, 2013 [June 14th, 2013]